Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itacitinib in Pre-Treated Myelofibrosis
NCT04629508Phase 2Completed
- Sponsor
- Incyte
- Start
- Jul 2021
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of itacitinib in myelofibrosis (MF), sponsored by Incyte. Started Jul 2021; status: completed.
02
Drugs
itacitinib
03
Conditions
myelofibrosis (MF)
Beyond the preview
Go deeper on NCT04629508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04629508.